SHA:600285 Market Cap

SHA:600285 has a market cap or net worth of 11.21 billion as of June 29, 2026. Its market cap has decreased by -16.17% in one year.

Market Cap

11.21B

Enterprise Value

10.33B

Revenue

3.96B

Ranking

n/a

PE Ratio

14.32

Stock Price

19.91

Market Cap Chart

Since January 2, 2001, SHA:600285's market cap has increased from 2.12B to 11.21B, an increase of 429.25%. That is a compound annual growth rate of 6.75%.

Market Cap History

Date	Market Cap	% Change
Jun 29, 2026	11.21B	-3.86%
Dec 31, 2025	11.66B	-6.54%
Dec 31, 2024	12.48B	29.34%
Dec 29, 2023	9.65B	31.14%
Dec 30, 2022	7.36B	-17.51%
Dec 31, 2021	8.92B	85.47%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Beijing Aosaikang Pharmaceutical	11.60B
Shenzhen Hepalink Pharmaceutical Group	11.52B
Zhejiang Hisun Pharmaceutical	11.50B
Guobang Pharma	11.50B
Tibet Rhodiola Pharmaceutical Holding Co.	11.33B
Zhejiang Jiuzhou Pharmaceutical	11.32B
Nanjing King-Friend Biochemical Pharmaceutical	11.04B
Zhejiang Medicine	10.70B

Market Cap Rankings